Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacologic principles for combination therapy.

Myron L Toews1, David B Bylund

  • 1Department of Pharmacology, University of Nebraska Medical Center, 985800 Nebraska Medical Center, Omaha, NE 68198-5800, USA. mtoews@unmc.edu

Proceedings of the American Thoracic Society
|November 4, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TGF-β1-induced miR-424 promotes pulmonary myofibroblast differentiation by targeting Slit2 protein expression.

Biochemical pharmacology·2020
Same author

Agonist-specific desensitization of PGE<sub>2</sub>-stimulated cAMP signaling due to upregulated phosphodiesterase expression in human lung fibroblasts.

Naunyn-Schmiedeberg's archives of pharmacology·2019
Same author

Leu<sup>8</sup> and Pro<sup>8</sup> oxytocin agonism differs across human, macaque, and marmoset vasopressin 1a receptors.

Scientific reports·2019
Same author

Biphasic changes in airway epithelial cell EGF receptor binding and phosphorylation induced by components of hogbarn dust.

Experimental lung research·2019
Same author

Binding Characteristics of Two Oxytocin Variants and Vasopressin at Oxytocin Receptors from Four Primate Species with Different Social Behavior Patterns.

The Journal of pharmacology and experimental therapeutics·2018
Same author

Today's research, tomorrow's health: focus on pharmacogenomics.

Personalized medicine·2018

This review explores drug combination principles, focusing on pharmacodynamics and pharmacokinetics. It proposes a framework for combination therapy, applicable to chronic obstructive pulmonary disease (COPD) and other diseases.

Area of Science:

  • Pharmacology
  • Drug Interactions
  • Therapeutics

Background:

  • Understanding drug actions is crucial for effective combination therapy.
  • Principles of drug combinations extend beyond specific diseases like chronic obstructive pulmonary disease (COPE).

Purpose of the Study:

  • To provide a pharmacologic foundation for understanding drug combinations.
  • To propose a framework for combination therapy with applications to COPD.

Main Methods:

  • Review of pharmacodynamic principles, including drug-receptor interactions and agonism.
  • Summary of pharmacokinetic factors and adaptive cellular changes relevant to prolonged drug action.
  • Discussion of different approaches to combination therapy with molecular rationales.

Related Experiment Videos

Main Results:

  • Emphasis on advances in drug-receptor interactions and signaling pathways.
  • Introduction of a framework for classifying and analyzing drug combination strategies.
  • Exploration of terminology and quantitative methods for assessing drug interactions.

Conclusions:

  • The article establishes fundamental pharmacologic principles for combination therapy.
  • It highlights the importance of pharmacodynamics and pharmacokinetics in designing effective drug combinations.
  • The proposed framework and principles are foundational for current and future COPD combination therapies.